Meaning
Regulatory documentation standards require electronic records and signatures to be securely linked to their respective modifications within computerized systems used in pharmaceutical production. Operational security relies on 21 cfr part 11 traceability to demonstrate that every change in a batch record is authentic, authorized, and non-repudiable. This safeguard stops at the boundary of paper-based recording systems.
Compliance Audit
Securing the digital chain of custody relies on automated audit trails that capture the operator identity and chronological timestamp of every entry. Auditing 21 cfr part 11 traceability before clinical production begins prevents regulatory stop-work orders. A manual oversight process cannot match the speed of automated verification.
This difference in processing capability dictates when a pilot line is ready to scale to high-volume output.
System Validation
Computer system validation runs verify that electronic signatures remain bound to their records. Stress testing 21 cfr part 11 traceability ensures that system bottlenecks do not drop essential metadata.
Data Integrity
Data loss during database failovers represents a major risk to regulatory approval. When 21 cfr part 11 traceability lacks redundant database synchronization, a recovery attempt might corrupt the historical record. The cost of calling validation complete without checking database failover scenarios is the loss of entire production runs.